Sotera Health Co. (NASDAQ: SHC) reported Q4 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $241 million versus the consensus estimate of $236.37 million.

GUIDANCE:

Sotera Health Co. sees FY2022 EPS of $0.93-$0.99, versus the consensus of $1.02. Sotera Health Co. sees FY2022 revenue of $1-1.03 billion, versus the consensus of $1.01 billion.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.